Rho GTPases: potential candidates for anticancer therapy
To access this article, please choose from the options below
PII: S0304-3835(03)00637-2
doi:10.1016/j.canlet.2003.08.035
© 2003 Elsevier Ireland Ltd. All rights reserved.
PII: S0304-3835(03)00637-2
doi:10.1016/j.canlet.2003.08.035
© 2003 Elsevier Ireland Ltd. All rights reserved.